SPOTLIGHT: Hassan bullish on Schering-Plough
Schering-Plough's CEO says its latest quarterly report underscores that the company's turnaround is on track. Fred Hassan (photo) said that its bottom line is growing faster than the top line, giving him cause to call his three-year plan a success. One analyst said that Schering-Plough would have to diversify beyond its successful cholesterol management franchise to continue its turnaround. Report
Be the first to comment
More stories about Schering Plough
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


